Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission-Niger Experience.

Ousmane, Sani; Ibrahim, Dan Dano; Goel, Ajay; Hendley, William S; Mainou, Bernardo A; Palmer, Tess; Diaha, Aissata; Greene, Sharon A; Mach, Ondrej

Ousmane, Sani; Ibrahim, Dan Dano; Goel, Ajay; Hendley, William S; Mainou, Bernardo A; Palmer, Tess; Diaha, Aissata; Greene, Sharon A; Mach, Ondrej.

Afiliação

Ousmane S; Centre de Recherche Médicale et Sanitaire, CERMES, Niamey, Niger.
Ibrahim DD; Centre de Recherche Médicale et Sanitaire, CERMES, Niamey, Niger.
Goel A; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
Hendley WS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mainou BA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Palmer T; Geospatial Research Analysis and Services Program, Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA.
Diaha A; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Greene SA; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland.

Open Forum Infect Dis ; 8(7): ofab210, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34295940

Palavras-chave

eradication; immunizations; poliomyelitis; seroprevalence; vaccine-preventable diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Níger

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google